Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Effects on dendritic cell function of the immunomodulator R-848

March 4, 2002

Avant signs research agreement with International Vaccine Institute for cholera vaccine

Feb. 25, 2002

Nongenotoxic porphyrin derivatives from Eukarion effective as ROS catalytic scavengers

Feb. 22, 2002

Cholera vaccines offered for licensing by NIH

Feb. 20, 2002

Mutant heat-labile enterotoxin as a potent adjuvant for oral influenza vaccination

Feb. 18, 2002

Pfizer synthesizes JAK3 inhibitors potentially useful as immunosuppressants

Feb. 15, 2002

New AstraZeneca compounds claimed for use in T-cell-mediated disorders

Feb. 14, 2002

Imunovir distribution agreement for North America extended

Feb. 6, 2002

FDA approves BioPort anthrax vaccine license supplements

Feb. 5, 2002

Antitumor effects demonstrated for rapamycin at immunosuppressive doses

Feb. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...